104721-52-0 (氧氟沙星杂质F(EP) 标准品,7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-)

9-氟-3-甲基-10-(4-甲基-4-氧代-1-哌嗪基)-7-氧代-2,3-二氢-7H-[1,4]恶嗪并[2,3,4-Ij]喹啉-6-羧酸乙酸盐(1:1);氧氟沙星-N-氧化物乙酸盐(杂质F);氧氟沙星杂质F;氧氟沙星杂质F(EP) 标准品;氧氟沙星EP杂质F;氧氟沙星N-氧化乙酸盐;

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-;Ofloxacin N-Oxide Acetic Acid Salt (Mixture of Diastereomers);7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo;Ofloxacin N-Oxide Ac;Ofloxacin N-Oxide Acetic Acid Salt (Mixture of Diastereomers);4-((3RS)-6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)-1,4-benzoxazin-10-yl)-1-methylpiperazine 1-oxide;Ofloxacin N-Oxide Acetic Acid Salt;Ofloxacin N-oxide,(+/-);Ofloxacin specified impurity F [EP];UNII-2400MFQ95B;Ofloxacin EP IMpurity F;OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS);4-(6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide;9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Aci;4-(6-carboxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide hydrochloride;9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Acetic Acid Salt;Ofloxacin N-Oxide Acetic Acid Salt (Mixture of Diastereomers);104721-52-0;AKOS030255912;Ofloxacin N-oxide;Q27253800;FT-0673217;2400MFQ95B;7-luoro-2-methyl-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;4-[(RS)-6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-10-yl]-1-methylpiperazine 1-Oxide Hydrochloride (Ofloxacin N-Oxide Hydrochloride);7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, N-oxide, (+/-)-;Ofloxacin N-oxide, (+/-)-;DTXSID801316290;CHEBI:183939;7-fluoro-2-methyl-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;OFLOXACIN IMPURITY F [EP IMPURITY];7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-;DS-015841;Levofloxacin n-oxide 2;OFLOXACIN IMPURITY F (EP IMPURITY);Ofloxacin specified impurity F;

MVLAUMUQGRQERL-UHFFFAOYSA-N

1S/C18H20FN3O5/c1-10-9-27-17-14-11(16(23)12(18(24)25)8-21(10)14)7-13(19)15(17)20-3-5-22(2,26)6-4-20/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)

FC1C=C2C(C(C(=O)O)=CN3C(C)COC(=C32)C=1N1CC[N+](C)(CC1)[O-])=O